- Home
- STKS vs PYXS Comparison
STKS vs PYXS Comparison
Compare STKS & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKS
- PYXS
- Stock Information
- Founded
- STKS 2004
- PYXS 2018
- Country
- STKS United States
- PYXS United States
- Employees
- STKS N/A
- PYXS N/A
- Industry
- STKS Restaurants
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- STKS Consumer Discretionary
- PYXS Health Care
- Exchange
- STKS Nasdaq
- PYXS Nasdaq
- Market Cap
- STKS 76.8M
- PYXS 79.4M
- IPO Year
- STKS N/A
- PYXS 2021
- Fundamental
- Price
- STKS $2.59
- PYXS $3.36
- Analyst Decision
- STKS Hold
- PYXS Strong Buy
- Analyst Count
- STKS 3
- PYXS 5
- Target Price
- STKS $4.50
- PYXS $7.75
- AVG Volume (30 Days)
- STKS 150.2K
- PYXS 819.7K
- Earning Date
- STKS 11-06-2025
- PYXS 11-11-2025
- Dividend Yield
- STKS N/A
- PYXS N/A
- EPS Growth
- STKS N/A
- PYXS N/A
- EPS
- STKS N/A
- PYXS N/A
- Revenue
- STKS $834,363,000.00
- PYXS $2,820,000.00
- Revenue This Year
- STKS $26.58
- PYXS N/A
- Revenue Next Year
- STKS $5.37
- PYXS N/A
- P/E Ratio
- STKS N/A
- PYXS N/A
- Revenue Growth
- STKS 96.64
- PYXS N/A
- 52 Week Low
- STKS $2.31
- PYXS $0.83
- 52 Week High
- STKS $5.26
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- STKS 46.87
- PYXS 64.03
- Support Level
- STKS $2.36
- PYXS $3.15
- Resistance Level
- STKS $2.91
- PYXS $3.82
- Average True Range (ATR)
- STKS 0.24
- PYXS 0.35
- MACD
- STKS 0.02
- PYXS 0.05
- Stochastic Oscillator
- STKS 19.22
- PYXS 68.62
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.